期刊文献+

DNA依赖的蛋白激酶和检查点激酶1对卵巢癌细胞周期阻滞的研究 被引量:1

Study on mechanism of DNA- PK and CHK1 on cell cycle block in ovarian cancer Skov3 cells
下载PDF
导出
摘要 目的:探讨DNA-PK和CHK1对卵巢癌Skov3的细胞周期阻滞的机制。方法:通过对DNA-PK shRNA和CHK1 shRNA的构建及有效干扰载体的筛选,流式细胞仪检测G2期。结果:转染DNA-PK shRNA的Skov3细胞和Hela细胞经2Gy X射线照射后进入G2期的细胞比率无差异;转染CHK1 shRNA的Skov3细胞经2Gy X射线照射后4h进入G2期的细胞比率显著高于Hela细胞(t=2.618,P=0.026),28h时明显低于Hela细胞(t=2.705,P=0.022);转染DNA-PK shRNA和CHK1 shRNA的Skov3细胞经2Gy X射线照射后4h进入G2期的细胞比率显著高于Hela细胞(t=2.965,P=0.014),28h时明显低于Hela细胞(t=2.302,P=0.044)。结论:干扰DNA-PK和CHK1的表达可增强卵巢癌细胞对辐射的敏感性。 Objectives: To explore the mechanism of DNA - PK and CHK1 on cell cycle block in ovarian cancer Skov3 cells. Method: We created DNA - PK shRNA and CHK1 shRNA and filtered the effective interference vectors. We detected the G2 phase by flow cytometry. Results: The proportions of Skov3 cells and Hela ceils transfected with DNA - PK shRNA and radia- ted by 2Gy X that entered the G2 phase showed no significant difference. The proportion of Skov3 cells transfected with CHK1 shRNA and radiated by 2Gy X that entered the G2 phase was significantly higher than of that of Hela cells at 4h of post - radiation ( t = 2.618, p = 0. 026), and significantly lower than of that of Hela cells at 28h of post - radiation ( t = 2. 705, P = 0. 022). The proportion of Skov3 cells transfected with DNA - PK shRNA and CHK1 shRNA that entered the G2 phase was significantly higher than that of Hela cells ( t = 2. 965, P = 0. 014) at 4h of post - radiation, and was significantly lower than that of Hela cells (t =2. 302, P =0. 044) at 4h of post - radiation. Conclusion: The interference with DNA - PK and CHK1 expression can en hance the sensitivity of ovarian cancer cells to radiation.
作者 廖琪
出处 《中国性科学》 2013年第11期26-29,共4页 Chinese Journal of Human Sexuality
基金 黑龙江省卫生厅项目(2012-489)
关键词 辐射敏感性 卵巢癌 DNA依赖的蛋白激酶 检查点激酶1 Radiation sensitivity Ovarian cancer DNA- PK CHK1
  • 相关文献

参考文献5

二级参考文献175

共引文献82

同被引文献15

  • 1Rooth C,Ovarian cancer:risk factors,treatment and management.Br J Nurs,2013,22(17):S23-30.
  • 2Yvonne Collins,Kevin Holcomb,Eloise Chapman-Davis,et al.Gynecologic cancer disparities:A report from the Health Disparities Taskforce of the Society of Gynecologic.
  • 3Cannistra SA.Cancer of the Ovary.N Engl J Med,2004,351(24):2519-2529.
  • 4Runnebaum IB,Stickeler E.Epidemiological and molecular aspects of ovarian cancer risk.J Cancer Res Clin Oncol,2001,127(2):73-79.
  • 5Jones MB,Krutzsch H,Shu H,et al.Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.Proteomics,2002,2(1):76.
  • 6Smith GP.Filamentous fusion phage:novel expression vectors that display cloned antigens on the virion surface.Science,1985,228(4705):1315-1317.
  • 7Kaplan G,Gershoni JM.A general insert label for pep-tide display on chimeric filamentous bacteriophages.Anal Biochem,2012,420(1):68-72.
  • 8Gautam A,Kapoor P,Chaudhary K,et al.Tumor homing peptides:as molecular probes for cancer therapeutics,diagnostics and theranostics.Curr Med Chem,2014,21(21):2367-2.
  • 9Cutler CS,Chanda N,Shukla R,et al.Nanoparticles and phage display selected peptides for imaging and therapy of cancer.Recent Results Cancer Res,2013(194):133-147.
  • 10D’Onofrio N,Caraglia M,Grimaldi A,et al.Vascular-homing peptides for targeted drug delivery and molecular imaging:Meeting the clinical challenges.Biochim Biophys.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部